Tsfg, LLC Grifols Sa Transaction History

Tsfg, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 14, 2021	SELL	$15.15 - $19.78 $1,560 - $2,037	-103 Closed	0 $0
Q4 2020 Jan 20, 2021	BUY	$16.86 - $19.67 $236 - $275	14 Added 15.73%	103 $2,000
Q3 2020 Oct 06, 2020	BUY	$15.4 - $20.16 $554 - $725	36 Added 67.92%	89 $2,000
Q4 2019 Jan 27, 2020	SELL	$19.57 - $23.52 $195 - $235	-10 Reduced 15.87%	53 $1,000
Q1 2019 Jan 27, 2020	BUY	$18.01 - $20.11 $1,134 - $1,266	63 New	63 $1,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.31B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Tsfg, LLC, based on Form 13F filings with the SEC.

Stay updated on Tsfg, LLC with notifications on news.